Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer

Published:2018-07-11 Issue:1 Volume:20 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Papadaki Chara,Stratigos Michalis,Markakis Georgios,Spiliotaki Maria,Mastrostamatis Georgios,Nikolaou Christoforos,Mavroudis Dimitrios,Agelaki Sofia

Funder

Hellenic Society of Medical Oncology

Anticancer Research Support Association

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-018-1001-3.pdf

Reference48 articles.

1. Brewster AM, et al. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst. 2008;100(16):1179–83.

2. Colleoni M, et al. Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the international breast cancer study group trials I to V. J Clin Oncol. 2016;34(9):927–35.

3. Davies C, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381(9869):805–16.

4. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007;7(11):834–46.

5. Pan H, et al. 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med. 2017;377(19):1836–46.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LINC00525 enhances ZNF460-regulated CD24 expression through the sponge miR-125a-5p to promote malignant progression of breast cancer;Journal of Cancer Research and Clinical Oncology;2024-06-24

2. BRCA Mutations and MicroRNA Expression Patterns in the Peripheral Blood of Breast Cancer Patients;ACS Omega;2024-04-03

3. Principles and Limitations of miRNA Purification and Analysis in Whole Blood Collected during Ablation Procedure from Patients with Atrial Fibrillation;Journal of Clinical Medicine;2024-03-25

4. Circulating microRNAs in Cancer: A 5-Year Update with a Focus on Breast and Lung Cancers;International Journal of Molecular Sciences;2024-03-08

5. Evaluation of miRNA-200c and βIII tubulin as promising markers for clinical decision making in locally advanced breast cancer patients receiving taxanes therapy;Gene Reports;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3